About Us
Therapeutic Systems Research Laboratories (TSRL), Inc. is a privately owned preclinical accelerator based in Ann Arbor, Michigan. Our 7,200 sq. ft. facility has 5,000 sq. ft. of wet lab space, and includes: analytical chemistry, formulation, cell culture, and in vivo testing.
Our Approach
We build on our success co-developing technologies through academic partnerships by providing infrastructure, expertise, and an avenue to non-dilutive funding. In an effort to advance our lead candidates into clinical development, we have developed an asset-centric portfolio built on promising lead-stage anti-infective compounds.
Below are academic, government, and industry organizations who have worked with us to develop better medicines for underserved populations.
The Preclinical Contract Research Organization (CRO) market is growing and expected to eclipse USD 11.3 billion by 2033, according to Research and Markets in Yahoo! Finance. With thousands of preclinical CROs in the US alone, selecting the right preclinical CRO becomes one of your most important decisions.